Oaktree Capital Management »

Travere Therapeutics shares owned by Oaktree Capital Management

Quarter-by-quarter ownership of Travere Therapeutics shares owned by Oaktree Capital Management from 13F filings

Historical chart of Oaktree Capital Management investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Oaktree Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Oaktree Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $26M 30M 0.86
2023-03-31 $1.5M 1.5M 0.98

More positions owned by Oaktree Capital Management

Torm Common Stock (TRMD)
Chesapeake Energy Corp Common Stock (CHK)
Garrett Motion Common Stock (GTX)
Sitio Royalties Corp Common Stock (STR)
State Street Corp Etf Put Option (SPY)
Infinera Corp Common Stock (INFN)
Anglogold Ashanti Common Stock (AU)
Liberty Global Common Stock Call Option (LBTYA)
Star Bulk Carriers Corp Common Stock (SBLK)
Sunopta Common Stock (STKL)
Talen Energy Corp Common Stock (TLN)
Freeport-mcmoran Common Stock (FCX)
Runway Growth Finance Corp Common Stock (RWAY)
Vista Energy Sab De Cv Common Stock (VIST)
California Resources Corp Common Stock (CRC)

View all positions for Oaktree Capital Management

Top funds holding Travere Therapeutics

Wolverine Asset Management
D. E. Shaw & Co
Oaktree Capital Management
Graham Capital Management
Silverback Asset Management
Capstone Investment Advisors
Highbridge Capital Management
CNH Partners
Point72 Asset Management
Lazard Asset Management
Readystate Asset Management
Affinity Asset Advisors
Agf Management
Advent Capital Management
BlackRock

View all funds holding Travere Therapeutics